LON:SBTX SkinBioTherapeutics (SBTX) Share Price, News & Analysis GBX 16 -0.25 (-1.54%) (As of 11:29 AM ET) Add Share Share Stock Analysis Stock AnalysisChartCompetitors About SkinBioTherapeutics Stock (LON:SBTX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get SkinBioTherapeutics alerts:Sign Up Key Stats Today's Range 15.66▼ 16.5050-Day Range 10.38▼ 18.1552-Week Range 7▼ 19.90Volume1.24 million shsAverage Volume976,674 shsMarket Capitalization£36.17 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewSkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis. The company has an agreement with Croda Plc; and operates two research programmes with the University of Manchester, an oral programme and an inflammation study. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.Read More… Buffett Dumps $982 Million in BofA Stock—What Does He Know? (Ad)Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.Get your FREE, no-obligation Wealth Protection Guide now Receive SBTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SkinBioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address SBTX Stock News HeadlinesSkinBioTherapeutics and Croda Secure Key Commercial DealNovember 19 at 8:50 AM | markets.businessinsider.comAIM WINNERS & LOSERS: SkinBioTherapeutics and Oxford Metrics make buysOctober 12, 2024 | lse.co.ukBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?November 21, 2024 | Golden Crest (Ad)Skinbiotherap. Share Chat (SBTX)September 19, 2024 | lse.co.ukProBiotix Health Plc (PBX.AQ)July 20, 2024 | finance.yahoo.comSkinBioTherapeutics plc (SBTX.L)May 1, 2024 | ca.finance.yahoo.comSkinBioTherapeutics First Half 2024 Earnings: UK£0.008 loss per share (vs UK£0.008 loss in 1H 2023)March 26, 2024 | finance.yahoo.comSkinBioTherapeutics announces research into wound healing bacteriumMarch 18, 2024 | lse.co.ukSee More Headlines SBTX Stock Analysis - Frequently Asked Questions How have SBTX shares performed this year? SkinBioTherapeutics' stock was trading at GBX 15.25 at the beginning of 2024. Since then, SBTX shares have increased by 4.9% and is now trading at GBX 16. View the best growth stocks for 2024 here. How were SkinBioTherapeutics' earnings last quarter? SkinBioTherapeutics plc (LON:SBTX) released its earnings results on Tuesday, March, 3rd. The company reported ($0.64) earnings per share for the quarter. How do I buy shares of SkinBioTherapeutics? Shares of SBTX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of SkinBioTherapeutics own? Based on aggregate information from My MarketBeat watchlists, some other companies that SkinBioTherapeutics investors own include OptiBiotix Health (OPTI), Ecora Resources (ECOR), Avacta Group (AVCT), Inspired (INSE), Lb-shell (LBP), Anglo African Oil & Gas (AAOG) and Avino Silver & Gold Mines (ASM). Company Calendar Last Earnings3/03/2020Today11/21/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:SBTX CUSIPN/A CIKN/A Webwww.skinbiotherapeutics.com Phone+44-161-4682760FaxN/AEmployees11Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-2,880,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-118.63% Return on Assets-61.18% Debt Debt-to-Equity Ratio2.66 Current Ratio6.57 Quick Ratio10.01 Sales & Book Value Annual Sales£21,949.00 Price / Sales1,648.11 Cash FlowGBX 1.78 per share Price / Cash Flow9.00 Book ValueGBX 2 per share Price / Book8.00Miscellaneous Outstanding Shares226,090,000Free FloatN/AMarket Cap£36.17 million OptionableNot Optionable Beta2.01 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report This page (LON:SBTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SkinBioTherapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share SkinBioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.